Spherity Blog

In May 2025, the Louisiana Board held its second public drug verification exercise—testing VRS, DSCSA Authority & ATP credentials ahead of the May 27 DSCSA exemption deadline. How did it compare to the first? What key insights did participants share?

Spherity hat zum zweiten Jahr in Folge die EcoVadis-Goldmedaille erhalten und gehört damit zu den besten fünf Prozent der weltweit bewerteten Unternehmen in Bezug auf Nachhaltigkeitsleistungen.

DSCSA enforcement is finally here after multiple delays, and ATP credentials are essential for compliance, data protection, and cybersecurity. So, how is ATP credential adoption progressing — and where do we stand today?

As the pharma industry moves toward DSCSA compliance, the VRS Provider Network highlights concerns with GLN Allow Lists and how ATP digital credentials address them.

PDG and FDA hosted the first of three DSCSA town halls—explore key points, industry insights, and key takeaways from the session.

Pharma industry updates and key takeaways from the 15th Annual Pharma Serialization & Supply Chain 2025 and HDA DMC 2025.

Spherity is honored as Digital Identity Solution of the Year 2025 by Enterprise Security Magazine, recognizing our impact and innovation.

If you're in digital credentialing, you're part of a global movement, investing in a future-proof, scalable tech. Let's explore examples!

SOC 2 report validates Spherity's commitment to protecting its customers' sensitive information.